ストックスクリーナーアプリを入手
291.24
0.19%
0.55
アフターアワーズ：
291.24
前日終値:
$290.69
開ける：
$290.87
24時間の取引高:
3.90M
Relative Volume:
2.18
時価総額：
$56.45B
収益：
$310.23B
当期純損益:
$1.69B
株価収益率:
33.79
EPS:
8.62
ネットキャッシュフロー:
$3.58B
1週間 パフォーマンス:
-0.38%
1か月 パフォーマンス:
+0.37%
6か月 パフォーマンス:
+15.78%
1年 パフォーマンス:
+32.06%
1日の値動き範囲:
$290.03
$295.25
1週間の範囲:
$285.98
$295.25
52週間の値動き範囲:
$218.65
$309.35
Cencora Inc Stock (COR) Company Profile
COR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
COR
Cencora Inc
|
291.24 | 56.66B | 310.23B | 1.69B | 3.58B | 8.62 |
|
MCK
Mckesson Corporation
|
719.51 | 89.51B | 359.05B | 3.30B | 5.23B | 25.83 |
|
CAH
Cardinal Health Inc
|
154.44 | 36.46B | 222.29B | 1.56B | 2.44B | 6.41 |
|
HSIC
Henry Schein Inc
|
69.99 | 8.96B | 12.50B | 314.00M | 421.00M | 2.44 |
|
YI
111 Inc Adr
|
8.17 | 68.73M | 2.05B | -45.99M | 5.54M | -0.5634 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-04 | 再開されました | Mizuho | Outperform |
| 2024-09-18 | ダウングレード | BofA Securities | Buy → Neutral |
| 2024-02-26 | 開始されました | Leerink Partners | Outperform |
| 2024-01-03 | 開始されました | Barclays | Overweight |
| 2023-12-14 | 開始されました | Wells Fargo | Equal Weight |
| 2023-03-31 | 開始されました | Citigroup | Buy |
| 2023-01-31 | 再開されました | Evercore ISI | Outperform |
| 2022-10-11 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-08-22 | 再開されました | Morgan Stanley | Equal-Weight |
| 2022-07-11 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2022-06-07 | アップグレード | Deutsche Bank | Hold → Buy |
| 2022-05-26 | アップグレード | Barclays | Equal Weight → Overweight |
| 2022-04-12 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2022-04-01 | 再開されました | Credit Suisse | Outperform |
| 2021-03-12 | 再開されました | Evercore ISI | In-line |
| 2021-02-04 | アップグレード | Evercore ISI | In-line → Outperform |
| 2021-02-02 | アップグレード | Cowen | Market Perform → Outperform |
| 2021-01-06 | アップグレード | BofA Securities | Underperform → Neutral |
| 2021-01-06 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2020-12-10 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
| 2020-12-03 | 開始されました | Mizuho | Neutral |
| 2020-08-06 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2020-07-15 | 開始されました | Barclays | Underweight |
| 2020-06-15 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-23 | 再開されました | Credit Suisse | Outperform |
| 2020-04-16 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2020-04-13 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2020-04-01 | アップグレード | JP Morgan | Neutral → Overweight |
| 2020-03-17 | アップグレード | Citigroup | Neutral → Buy |
| 2020-02-11 | ダウングレード | BofA/Merrill | Buy → Underperform |
| 2020-02-07 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2019-09-12 | 開始されました | Deutsche Bank | Hold |
| 2019-07-10 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-11 | 開始されました | Guggenheim | Buy |
| 2019-04-10 | ダウングレード | BofA/Merrill | Buy → Underperform |
| 2019-04-10 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2019-02-11 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2019-01-17 | 開始されました | UBS | Buy |
| 2018-12-10 | ダウングレード | Jefferies | Buy → Hold |
| 2018-10-26 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-09-20 | 開始されました | Berenberg | Buy |
| 2018-07-17 | 再開されました | Stifel | Hold |
| 2018-04-09 | 開始されました | MoffettNathanson | Buy |
| 2018-03-12 | アップグレード | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-03-12 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2017-09-25 | 開始されました | JP Morgan | Neutral |
| 2017-09-22 | 開始されました | William Blair | Outperform |
すべてを表示
Cencora Inc (COR) 最新ニュース
Here's Why You Should Add Cencora Stock to Your Portfolio Now - MSN
Nephron Research Adjusts Cencora Price Target to $335 From $325 - marketscreener.com
Cencora, Inc. (COR) Announces Board Changes: New Appointment and Resignation - GuruFocus
Cencora Announces New Board Appointment Amid Recent Resignation - TipRanks
Cencora Appoints Lori J. Ryerkerk To Board - citybiz
Cencora appoints new board member to boost growth By Investing.com - Investing.com India
Cencora Elects Lori J. Ryerkerk to Its Board of Directors | COR Stock News - GuruFocus
Cencora appoints new board member to boost growth - Investing.com
Cencora Elects Lori J. Ryerkerk To Its Board Of Directors - marketscreener.com
Global Supply Chain Expert and Former Fortune 500 CEO Lori Ryerkerk Strengthens Cencora Board - Stock Titan
Baird Adjusts Price Target on Cencora to $351 From $350, Maintains Outperform Rating - marketscreener.com
Beat the Market the Zacks Way: GE Aerospace, Monster Beverage, Cencora in Focus - MSN
Cencora Completes €1 Billion Senior Notes Sale - TipRanks
Insider Sell: Steven Collis Sells Shares of Cencora Inc (COR) - GuruFocus
Cencora, Inc. (COR) Announces €1 Billion Senior Notes Offering - GuruFocus
Cencora Enters €1 Billion Senior Notes Agreement - TipRanks
Robust Results Lifted Cencora (COR) Amid Upgraded Outlook - Insider Monkey
Jim Cramer Highlights Cencora (COR) “Knocked It Out of The Park” - Insider Monkey
8 Stocks on Jim Cramer’s Radar Recently - Insider Monkey
Cencora, Inc. concludes securities offering without stabilisation action By Investing.com - Investing.com Nigeria
Insider Sell Alert: Lon Greenberg Sells 3,000 Shares of Cencora Inc (COR) - GuruFocus
Cencora Director Sells Stock in Major Transaction - TipRanks
Cencora Continues To Deliver As A Healthcare Distributor With Further Growth Signs - Seeking Alpha
Cencora, Inc. concludes securities offering without stabilisation action - Investing.com
Cencora, Inc. announces potential market stabilization measures By Investing.com - Investing.com South Africa
Cencora Reports Strong Q2 2025 Results, Raises Outlook - MSN
Cencora Files For Two-Part Senior Notes Offering Size Not Disclosed- SEC Filing - marketscreener.com
Cencora, Inc. announces potential market stabilization measures - Investing.com
Cencora increases FY2025 EPS guidance to $15.70-$15.95 amid specialty growth - MSN
Cencora's (NYSE:COR) Soft Earnings Don't Show The Whole Picture - Yahoo Finance
Do Wall Street Analysts Like Cencora Stock? - MSN
Transcript : Cencora, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 11 - marketscreener.com
JPMorgan Adjusts Price Target on Cencora to $326 From $301, Maintains Overweight Rating - marketscreener.com
Beat the Market the Zacks Way: Limbach, Stride, Cencora in Focus - Yahoo Finance
Is It Smart To Buy Cencora, Inc. (NYSE:COR) Before It Goes Ex-Dividend? - Yahoo Finance
Cencora, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - Yahoo Finance
Cencora Inc. stock underperforms Thursday when compared to competitors - MSN
Here's Why Cencora (COR) is a Strong Momentum Stock - Yahoo Finance
Cencora (COR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - MSN
Citigroup Maintains Buy Rating and Raises Price Target for Cencora (COR) | COR Stock News - GuruFocus
Cencora (COR) Receives Increased Price Target from Baird Analyst | COR Stock News - GuruFocus
Cencora (COR) Reaches New Heights with Increased Price Target | COR Stock News - GuruFocus
Cencora, Inc. (COR) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
Cencora Ups Profit Forecast Thanks To Drug Demand - Finimize
Cencora Inc (COR) 財務データ
収益
当期純利益
現金流量
EPS
0.29%
2.76%
大文字化:
|
ボリューム (24 時間):